Key Stats | |
---|---|
Open | $36.13 |
Prev. Close | $35.77 |
EPS | - |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 35.93 | 36.32 |
52 Week Range | 26.13 | 37.08 |
Ratios | |
---|---|
P/B Ratio | - |
Revenue | - |
Operating M. % | - |
Earnings | - |
Earnings Growth % | - |
EBITDA Margin % | - |
ROE % | - |
EPS | - |
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
Enact Re, Ltd. Receives A- Rating from S&P Global Ratings
Genworth Financial (GNW) Q2 2024 Earnings Call Transcript
Will High Costs Weigh on Marsh & McLennan's (MMC) Q2 Earnings? - Zacks Investment Research
Enact Completes XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
MTG or ACT: Which Multiline Insurance Stock is Better-Positioned?